verified SJR 0,781 · Q2 • database Scopus / SJR & Web of Science indexed

Switzerland · S. Karger AG

workspace_premium Q2 — Psychiatry and Mental Health lock Subscription

Dementia and Geriatric Cognitive Disorders

Dementia and Geriatric Cognitive Disorders is a journal indexed in SJR in Psychiatry and Mental Health and Cognitive Neuroscience with an H index of 127. It has an SJR impact factor of 0,781 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,781.

Dementia and Geriatric Cognitive Disorders focuses its scope in these topics and keywords: patients, cognition, dementia, injuryvitamin, caffeine, barrier, beliefs, chinese, vascular, strategic, ...

ISSN: 1420-8008

Publisher: S. Karger AG

Category: Psychiatry and Mental Health

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,781 Q2

H-index 127

Acceptance rate pie_chart

23% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,781

H-index

127

Docs (year)

Docs 3y

190

Total refs

2132

Cites 3y

478

Citable 3y

187

Cites/Doc 2y

1.96

Ref/Doc

43.51

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer"s Disease

White Matter Lesions Impair Initiation of FAS Flow

Different Classification Systems Yield Different Dementia Occurrence among Nonagenarians and Centenarians

Diagnosis and Treatment of Depression in Alzheimer"s Disease

Dexamethasone Inhibits TNF-a Synthesis More Effectively in Alzheimer's Disease Patients than in Healthy Individuals

Decrease of GABAergic Markers and Arc Protein Expression in the Frontal Cortex by Intraventricular 192 IgG-Saporin

CT Brain Findings in Clinical Dementia Investigation -Underestimation of Mixed Dementia

CSF Lactate Dehydrogenase Activity in Patients with Creutzfeldt-Jakob Disease Exceeds That in Other Dementias

Correlation of the Expression Level of C1q mRNA and the Number of C1q-Positive Plaques in the Alzheimer Disease Temporal Cortex

Cooperation and Networking on White Matter Disorders: The European Task Force on Age-Related White Matter Changes

Constructional Apraxia in Alzheimer's Disease: Association with Occipital Lobe Pathology and Accelerated Cognitive Decline

Comparison of Brain Perfusion in Corticobasal Degeneration and Alzheimer's Disease

SHOW MORE ARTICLES

Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer's Disease

A Comparison of Medial and Lateral Temporal Lobe Atrophy in Dementia with Lewy Bodies and Alzheimer's Disease: Magnetic Resonance Imaging Volumetric Study

Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-Olds

Biochemical and Molecular Characterization of Neurofibrillary Degeneration in Frontotemporal Dementias

Association of the Neprilysin Gene with Susceptibility to Late-Onset Alzheimer's Disease

Apolipoprotein E Genotype, Vascular Risk and Early Cognitive Impairment in an African Caribbean Population

Apolipoprotein E Gene Polymorphism in Indian Patients with Alzheimer's Disease and Vascular Dementia

An Interleukin-6 Promoter Variant Is Not Associated with an Increased Risk for Alzheimer's Disease

An Attempt to Determine the Benefits of a 'Home-for-Life' Principle in Residential Care for People with Dementia and Behavioural Problems: A Comparative Cohort Study

Alpha-1-Antichymotrypsin Gene Polymorphism and Risk for Sporadic Alzheimer's Disease in a German Population

Advances in the Neuropsychopharmacologic Management of Behavioral Alterations in Alzheimer"s Disease

A Quantitative and Immunohistochemical Study on Apolipoprotein E in Brain Tissue in Alzheimer's Disease

FAQs

Dementia and Geriatric Cognitive Disorders has an SJR of 0,781 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Dementia and Geriatric Cognitive Disorders is 23%.

Dementia and Geriatric Cognitive Disorders

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Dementia and Geriatric Cognitive Disorders?

What is the APC / publication cost?

What is the acceptance rate?